SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-23-067374
Filing Date
2023-03-10
Accepted
2023-03-10 14:04:28
Documents
2
Group Members
JOSEPH EDELMANPERCEPTIVE LIFE SCIENCES MASTER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G d461854dsc13g.htm SC 13G 58744
2 EX-99.1 d461854dex991.htm EX-99.1 4167
  Complete submission text file 0001193125-23-067374.txt   64668
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87950 | Film No.: 23723045
SIC: 2834 Pharmaceutical Preparations

Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G